U.S. Ambassador Johnson and UK’s Sir Nicholas Soames to join Bermuda Premier at Executive Forum in London
The United States Ambassador to the United Kingdom (UK), Robert Wood Johnson, and the UK’s Rt. Hon. Sir Nicholas Soames, former defence minister and former Conservative Member of Parliament for Mid Sussex, will join Bermuda’s Premier, the Hon. E. David Burt, JP, MP, at an Executive Forum in London this month to highlight the historic and successful economic relationship that exists between Bermuda, the U.S. and the UK.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191113005627/en/
Bermuda Executive Forum London 2019 opening panel. (Photo: Business Wire)
The keynote conversation between Ambassador Johnson, Sir Nicholas Soames and the Premier will explore the implications of global trends, address key challenges from Brexit to U.S. tax reform, and shed light on new opportunities to further develop economic ties. The discussion will be moderated by Fiona Luck, a Non-Executive Director on the Lloyd’s of London Franchise Board, whose more than 30 years’ experience in insurance and reinsurance will bring valuable insights from Bermuda’s traditional powerhouse industry, a significant contributor to the world’s economy.
Under the theme ‘Navigating Disruption for Positive Change’, the Bermuda Executive Forum London takes place Tuesday, November 26 and is hosted by the Bermuda Business Development Agency (BDA). It will bring together government officials, regulators and industry leaders for a full-day agenda of engaging panel discussions and keynotes across a range of sectors including re/insurance, asset management, family offices, financial services and technology. A networking reception will close the event in the evening.
“We look forward to welcoming Ambassador Johnson and Sir Nicholas Soames to our forum in London. Their participation, alongside our Premier, will ensure a dynamic and informative start to the day,” said Roland Andy Burrows, CEO of the BDA. “The U.S. and the UK are highly valued Bermuda partners and we have long enjoyed robust, mutually beneficial relationships that continue to thrive in many areas. As world-leading and innovative financial centres there’s clearly a lot of common ground for collaboration where we can work together to grow business and investment for the benefit of all.”
Ambassador Johnson was nominated by President Trump on June 22, 2017. He made his first official visit to Bermuda in July this year when he spoke about the strength and long-term nature of Bermuda’s relationship with the U.S. and expressed his admiration for the island’s unique capabilities and world-class expertise.
A prominent businessman and philanthropist, Ambassador Johnson served for more than 30 years as the Chairman and CEO of The Johnson Company, a private asset management firm founded in 1978, and as the Chairman and CEO of the New York Jets football team and New York Jets Foundation. He is the Founding Chairman of the Lupus Research Alliance and worked for many years with the Juvenile Diabetes Research Foundation.
Former Conservative Party grandee and grandson of the great wartime leader Sir Winston Churchill, Sir Nicholas served until recently as the Member of Parliament for Mid Sussex. Prior to that, he was the UK Minister of State for the Armed Forces from 1994-1997. Having previously worked as a stockbroker and on the staff of a U.S. Senator in Washington D.C, he has specialist knowledge in the fields of Europe, defence, international affairs, aviation and trade and industry. He also has a longstanding involvement in the Insurance and Reinsurance business as a Senior Advisor to Marsh the Global Leader in Broking and Risk Management. In March earlier this year, Sir Nicholas met with Premier Burt as part of a wider Bermuda Government trip to the UK and Brussels.
Mr Burrows added, “Against a backdrop of global economic and digital disruption, our event provides a platform for an open dialogue on how best to embrace change to bring about positive transformations and future growth. It is an ideal opportunity to directly engage with partners in the UK market, to share knowledge and forge new connections with prospective businesses and investors who would benefit from Bermuda’s global connectivity combined with its quality, stability and ease of doing business.”
The BDA forum builds on a two-day event held in London last year opened by Premier Burt with more than 50 experts as speakers and panellists. The event attracted close to 200 delegates encompassing a wide range of industries, and featured the UK’s Chris Holmes, Lord of Richmond MBE, and Bermudian Chief Executive of American International Group (AIG), Brian Duperreault.
To register for the Bermuda Executive Forum London 2019, click here.
CONNECTING BUSINESS
The BDA encourages direct investment and helps companies start up, re-locate or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191113005627/en/
Contact information
MEDIA CONTACT:
Nicola Stevens
Director of Communications and PR
nstevens@bda.bm
+1 441 292 7774
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release
Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release
Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct
Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release
Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we
Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release
AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by
illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release
illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom